Xavier De Mollerat Du Jeu

This inventor holds 18 USPTO granted patents and 11 published patent applications and 4 EPO patents, primarily in Gene Delivery Technology. Top assignees: Life Technologies Corporation, Life Technologies Holdings Pte Limited, Sangamo Therapeutics, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xavier De Mollerat Du Jeu. Retrieved from https://idiyas.com/inventor/xavier-de-mollerat-du-jeu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 11)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 33(Granted Patents)

Company Filing History:

18 out of 1,896

Life Technologies Corporation

patents

1 out of 44

Life Technologies Holdings Pte Limited

patents

1 out of 154

Sangamo Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Electroporation

Cationic Lipids

Transfection Reagents

Lentiviral Production

Adeno Associated Virus

Membrane-Penetrating Peptides

Nuclease Delivery

Ribonucleoprotein Agents

Cell Delivery

Suspension Systems

Tissue-Specific Delivery

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12644088 - Systems, methods, and devices for electroporation of cell-containing fluid (2026-06-02),

2. 12521447 - Cationic lipid compositions for tissue-specific delivery (2026-01-13),

3. 12458700 - Amine-containing transfection reagents and methods for making and using same (2025-11-04),

4. 12365919 - Serum-free suspension system for lentiviral production (2025-07-22),

5. 12152248 - Membrane-penetrating peptides to enhanced transfection and compositions and methods for using same (2024-11-26),

6. 12077784 - Suspension system for adeno associated virus production (2024-09-03),

7. 11872285 - Compositions and methods for efficient delivery of molecules to cells (2024-01-16),

8. 11690921 - Delivery of target specific nucleases (2023-07-04),

9. 11608491 - Suspension system for adeno associated virus production (2023-03-21),

10. 11464863 - Amine-containing transfection reagents and methods for making and using same (2022-10-11),

11. 11414675 - Serum-free suspension system for lentiviral production (2022-08-16),

12. 10829787 - Ribonucleoprotein transfection agents (2020-11-10),

13. 10792362 - Compositions and methods for efficient delivery of molecules to cells (2020-10-06),

14. 10760098 - Membrane-penetrating peptides to enhance transfection and compositions and methods for using same (2020-09-01),

15. 10406237 - Amine-containing transfection reagents and methods for making and using same (2019-09-10),

As an assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide information about inventor Xavier de Mollerat du Jeu.

Title: The Innovative Work of Xavier de Mollerat du Jeu

Introduction: Xavier de Mollerat du Jeu is a prolific inventor based in Encinitas, CA, with a remarkable portfolio of 12 patents to his name.

Latest Patents: Among his latest inventions is a groundbreaking patent titled "Compositions and Methods for Efficient Delivery of Molecules to Cells." This patent focuses on lipid aggregate compositions that enhance the delivery of various biologically active molecules, including nucleic acids and proteins, into cells and tissues. Another notable patent is for "Delivery of Target Specific Nucleases," which details the use of lipid nanoparticles for transferring nucleic acids to cells.

Career Highlights: Xavier de Mollerat du Jeu has made significant contributions to the field of biotechnology, having worked at renowned companies such as Life Technologies Corporation and Sangamo Therapeutics, Inc.

Collaborations: Throughout his career, Xavier de Mollerat du Jeu has collaborated with talented individuals in the industry, including coworkers like Nektaria Andronikou and Xin Yu.

Conclusion: In conclusion, Xavier de Mollerat du Jeu's innovative work in the realm of biotechnology and cell delivery systems has earned him a reputation as a notable inventor. His patents showcase his dedication to advancing scientific research and improving the efficiency of delivering biologically active molecules to cells and tissues.

Profile summary based on public USPTO records.